Edition:
India

People: New World Development Co Ltd (0017.HK)

0017.HK on Hong Kong Stock

10.60HKD
16 Nov 2018
Change (% chg)

HK$0.06 (+0.57%)
Prev Close
HK$10.54
Open
HK$10.58
Day's High
HK$10.60
Day's Low
HK$10.46
Volume
12,938,920
Avg. Vol
11,259,840
52-wk High
HK$13.00
52-wk Low
HK$9.67

Lee, Luen-Wai 

Mr. Lee Luen-Wai (John) is Independent Non-executive Director of New World Development Company Limited. Mr. Lee is the chairman of the Audit Committee, and a member of the Remuneration Committee and the Nomination Committee of the Board of Directors of the Company. Mr. Lee is the managing director and chief executive officer of Lippo Limited, an executive director and the chief executive officer of Lippo China Resources Limited and Hongkong Chinese Limited, as well as an independent non-executive director of UMP Healthcare Holdings Limited, all being listed public companies in Hong Kong. Mr. Lee is also a non-executive nonindependent chairman of Healthway Medical Corporation Limited, a company listed on the sponsor-supervised listing platform of the Singapore Exchange Securities Trading Limited. Mr. Lee was an independent non-executive director of New World China Land Limited (a listed public company in Hong Kong until its delisting on 4 August 2016) up until his resignation on 1 September 2016. Mr. Lee is a Fellow of The Institute of Chartered Accountants in England and Wales, the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants. He was a partner of Price Waterhouse (now PricewaterhouseCoopers) in Hong Kong and has extensive experience in corporate finance and capital markets. Mr. Lee is an Honorary Fellow of the City University of Hong Kong and a Justice of Peace in Hong Kong. He serves as a member on a number of Public Boards and Committees including as a Trustee of the Hospital Authority Provident Fund Scheme and the Chairman of its Investment Committee, a member of the Public Service Commission as well as a member of the Appeal Boards Panel (Education).

Basic Compensation

Total Annual Compensation, HKD 800,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 100,000
Fiscal Year Total, HKD 900,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kar-Shun Cheng

55,200,000

Chi-Kong Cheng

33,200,000

Wai Hoi Doo

500,000

Tak-Cheong Au

8,900,000

Chi-Heng Cheng

2,600,000

Chi-man Cheng

13,900,000
As Of  30 Jun 2017